VIVA 2018 focuses on the critical issues in vascular medicine

In the arterial space, VIVA 2018 focused on the fact that there is an increasing awareness of limb threatening ischaemia coupled with an increase in interventional tools, but no clear defined pathway for treatment. There is also...

Lutonix 014 DCB gathers first randomised evidence of positive safety and efficacy when used in arteries below the knee

Six-month outcomes of the Lutonix BTK IDE trial, a multicentre randomised controlled trial using the Lutonix 014 drug-coated balloon (DCB; BD), has demonstrated that the DCB is safe and effective to use for the treatment of narrowed or obstructed...

TOBA II shows repairing dissections after angioplasty “clearly augments” outcomes for PAD patients

Thomas Zeller (Bad Krozingen, Germany) delves into data and design of the TOBA II (Tack Optimized Balloon Angioplasty II) trial with principal investigator William Gray (Philadelphia, USA) for Vascular News. Gray, who presented the one-year findings...

VIVA 2018

    Subscribe to receive the very best in medical videos

    /* ]]> */